Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2017-02-24

First hormone replacement therapy for parathyroid disorder

View source ↗

Summary

The European Medicines Agency announces the first hormone replacement therapy for a parathyroid disorder, marking a new treatment option.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications